Post Reply
101-120 of 212
A good tikam??pr a wonderful bet??
SmallSmall ( Date: 23-Dec-2024 09:28) Posted:
|
PROPOSED RENOUNCEABLE NON-UNDERWRITTEN RIGHTS ISSUE OF UP TO 264,078,029 NEW ORDINARY SHARES IN THE CAPITAL OF META HEALTH LIMITED
1 for 4 @ $0.006.
Next one to tikam ...
1 for 4 @ $0.006.
Next one to tikam ...
This is the few laggards that has not moved in this small pennies run.
SmallSmall ( Date: 11-Sep-2024 09:07) Posted:
|
2. AGREEMENT TO SETTLEMENT 2.1
The Board wishes to update that MCE and Mr Chua have attended a mediation under the Law Society Mediation Scheme on 6 September 2024, and both parties have agreed to settle the issues arising from the Suit (the &ldquo Settlement&rdquo ). Accordingly on the same day, MCE entered into a written settlement agreement with Mr Chua (the &ldquo Settlement Agreement&rdquo ). 2.2 Pursuant to the Settlement Agreement, MCE will pay the agreed settlement amount to Mr Chua over three equal instalments, by 1 October 2024, 1 November 2024 and 1 December 2024. In the event of a default of any of the instalment payments, the whole of the balance outstanding shall become due and payable forthwith. 2.3 The Settlement Agreement will be in full and final settlement of the issues as stated in the Suit and the issues raised in the mediation case statements tendered for the purpose of the mediation held on 6 September 2024. In addition, the parties shall bear their own legal costs. 2.4 Mr Chua will file a notice of discontinuance of the Suit within seven days after the last instalment payment is received on 1 December 2024, subject to any contrary directions by the Court. 3.
FINANCIAL IMPACT The Settlement is not expected to have a material impact on the consolidated net tangible assets per share and earnings per share of the Group for the current financial year ending 31 December 2024.
The Board wishes to update that MCE and Mr Chua have attended a mediation under the Law Society Mediation Scheme on 6 September 2024, and both parties have agreed to settle the issues arising from the Suit (the &ldquo Settlement&rdquo ). Accordingly on the same day, MCE entered into a written settlement agreement with Mr Chua (the &ldquo Settlement Agreement&rdquo ). 2.2 Pursuant to the Settlement Agreement, MCE will pay the agreed settlement amount to Mr Chua over three equal instalments, by 1 October 2024, 1 November 2024 and 1 December 2024. In the event of a default of any of the instalment payments, the whole of the balance outstanding shall become due and payable forthwith. 2.3 The Settlement Agreement will be in full and final settlement of the issues as stated in the Suit and the issues raised in the mediation case statements tendered for the purpose of the mediation held on 6 September 2024. In addition, the parties shall bear their own legal costs. 2.4 Mr Chua will file a notice of discontinuance of the Suit within seven days after the last instalment payment is received on 1 December 2024, subject to any contrary directions by the Court. 3.
FINANCIAL IMPACT The Settlement is not expected to have a material impact on the consolidated net tangible assets per share and earnings per share of the Group for the current financial year ending 31 December 2024.
Please read the financial report released on 8 Aug 2024.
It doesn' t look good. Expect sell down on Monday.
It doesn' t look good. Expect sell down on Monday.
went back to $0.009...this one is dead....haiz..
SmallSmall ( Date: 29-Jul-2024 09:39) Posted:
|
This one 50% 50% only. Buy $0.01 and see what happens
Meta Health agrees to out-of-court settlement with former executives of two subsidiaries
HEALTHCARE technology company Meta Health : 5DX +10% has reached an out-of-court settlement with two former executives of its wholly owned subsidiaries, Gainhealth and 5Digital.
In a bourse filing on Wednesday (Jan 10), Meta Health said both units have entered into and executed a written settlement agreement with Dr Vasanthan Metupalle, the former chief medical officer of 5Digital, and Jagannathan Padmaja Sakthi, a former director of Gainhealth who is also Dr Vasanthan&rsquo s spouse.
In May 2023, Gainhealth and 5Digital commenced legal proceedings against Dr Vasanthan, Sakthi, as well as 1Life Healthcare and Aventres Enterprise Limited, two entities which were not part of Meta Health.
All were accused of deceiving the group following the discovery of &ldquo alleged irregularities&rdquo in some of Gainhealth&rsquo s sale transactions in March 2023. The lawsuit filed sought to recover some of the group&rsquo s losses and wrongful payments made in connection to the transactions.
Meta Health announced on Sep 15, 2023, that Gainhealth and 5Digital had been awarded about S$1.4 million in damages and costs. Of that sum, about S$1.3 million will be payable with interest at 5.33 per cent per annum from the date the originating claim was filed.
In its update on Wednesday, Meta Health said that Dr Vasanthan and Sakthi have agreed, among others, to pay the full amount of damages claimed by Gainhealth and 5Digital in the lawsuit, as well as contribution towards costs.
The settlement amount will be paid in two tranches, with the first tranche payable once Dr Vasanthan sells his share of a certain property. The second tranche will be payable within 10 calendar months thereafter or by Dec 31, 2024, whichever is the earlier.
In addition, Gainhealth and 5Digital will proceed to file a notice of discontinuance in the lawsuit once they receive the first tranche of the settlement amount from Dr Vasanthan and Sakthi.
Following this, no further action will be taken by both subsidiaries against the defendants regarding the matters raised in the suit, including any further enforcement action arising from any judgments obtained in the suit. Gainhealth and 5Digital will also inform the Singapore Police Force that the suit has been &ldquo settled amicably&rdquo , Meta Health said.
The company noted, however, that should Dr Vasanthan and Sakthi breach any terms of the settlement agreement or default in payments prior to the suit&rsquo s discontinuance, they shall be deemed to have &ldquo irrevocably and unconditionally consented to final judgment being entered against them in the suit&rdquo , and will have no right to any recourse or defence against such final judgment.
Accordingly, Gainhealth and/or 5Digital is also entitled to commence a fresh legal action against them arising from and/or in connection with such breach.
The settlement is expected to have a positive impact on the consolidated net tangible assets per share and earnings per share of the group for the current financial year ending Dec 31, 2024.
Got action liao
Now down to 0.009 la
piscesmonkey ( Date: 27-Nov-2023 15:46) Posted:
|
1 mouth 5.9m shares bought up. not sure who keep buying at 10. from friday and today. already collected 13m shares at 10
piscesmonkey ( Date: 27-Nov-2023 12:32) Posted:
|
Going 15 soon.
Joelton ( Date: 27-Nov-2023 11:25) Posted:
|
Meta Health
On Nov 22, Meta Health : 5DX +22.22% Group CEO Bernard Ng Kee Huat acquired five million shares at S$0.009 per share. With a consideration of S$45,000 this increased his direct interest in the Catalist-listed company from 1.11 per cent to 1.59 per cent.
Dr Ng is a medical and clinical affairs leader with global, regional, and local experience in the pharmaceutical and consumer health industry. He previously served as chief medical officer, head of global medical & clinical affairs for Bayer Consumer Healthcare.
He is also an angel investor and advises fund management companies and is an active proponent of leveraging digital technologies and data.
The principal activities of the group consist of investment holding, metal stamping and manufacturing of tools and fixtures, as well as healthcare business of telemedicine, nursing services and e-pharmacy.
CEO bought rights 5.4m shares at 0.0055 and bought 5m shares at 0.009. he bought alot above 0.029
Blue Ocean bought rights 81.9m shares at 0.0055 become SSH
Blue Ocean bought another 8m shares at 0.006 at open market
Blue Ocean bought rights 81.9m shares at 0.0055 become SSH
Blue Ocean bought another 8m shares at 0.006 at open market
The 6.2 mil selling at 11 will be gone soon!
piscesmonkey ( Date: 24-Nov-2023 14:39) Posted:
|
today huge buying up during lunch matching at 10
luckyboy22 ( Date: 24-Nov-2023 14:38) Posted:
|
Dono who is buying but I hope it' s the ceo or top management people.
piscesmonkey ( Date: 24-Nov-2023 14:16) Posted:
|
CEO keep buying? something brewing? Company turnaround soon?
Meta Health disposes of Suzhou metal business subsidiary for RMB17.2 mil
Meta Health Limited has disposed of MCE Technologies (Suzhou) or MCE Suzhou, its Suzhou metal business, to Jiangsu TNS Industry Science & Technology for a cash consideration of RMB17.2 million ($3.3 million).
MCE Technologies, a wholly-owned subsidiary of Meta Health 5DX 12.5% , had entered into an equity transfer agreement with Jiangsu TNS on Nov 20. MCE Suzhou is a wholly-owned subsidiary of MCE Technologies.
The equity transfer agreement will also see the waiver and transfer of some RMB30.7 million of debt owed by MCE Suzhou to MCE Holdings and other members of the group to Jiangsu TNS. It will also see the waiver of RMB305,589 of debt owed to MCE Suzhou by some members of the group.
Meta Health, which is now in the healthcare technology and services sector, was formerly known as Metal Component Engineering, which focused on mechanical manufacturing solutions. The company proposed its name change at an extraordinary general meeting (EGM) held in January 2022.
According to Meta Health, the proposed transactions will allow it to exit from its loss-making metal business completely. The company recently completed the disposal of its other wholly-owned operating subsidiaries in the metal business in Malaysia and Thailand, MCE Technologies Sdn Bhd and MCT Thailand Co. Ltd., in November this year.
The proposed transactions will also allow the company to exit from its investment in MCE Suzhou at a lower cost than winding the latter up.
The company adds that its metal business operations were severely affected by the impact of the Covid-19 pandemic on the economy. In the FY2022 ended Dec 31, 2022, Meta Health recorded a 21.5% y-o-y decline in its revenue of $33.8 million mainly due to a decline in revenue for its metal business, which fell by 23.7% y-o-y. In particular, total revenue from MCE Suzhou decreased by 24.2% y-o-y $13.5 million in FY2022, and recorded a loss of $0.7 million in FY2022 as compared to a profit of $0.5 million in FY2021.
More headwinds were faced in the 1HFY2023 ended June 30, which &ldquo consequently had an adverse effect on [Meta Health&rsquo s] financial condition and operating results&rdquo .
Furthermore, the proposed transactions will allow the company to deploy more resources to focus on growing and developing its healthcare portfolio in line with its diversification into the healthcare technology and services sector.
Upon the completion of the proposed transaction, Meta Health will net RMB1.1 million or $203,128 in proceeds, which will be used for general corporate and working capital purposes.
By today' s closing we can expect the px to do better in the coming days.